Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study-Reference-Cited by-同舟云学术

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study

Published:2004 Issue:19 Volume:10 Page:2791
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Ren Zheng-Gang

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference31 articles.

1. Hepatocellular Carcinoma

2. Zhang S, Li L, Lu F. [Mortality of primary liver cancer in China from 1990 through 1992]. Zhonghua Zhongliu Zazhi 1999;21:245-249.

3. Hepatocellular carcinoma

4. Predictors and patterns of recurrence after resection of hepatocellular carcinoma

5. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study;Langenbeck's Archives of Surgery;2024-03-15

3. Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy;Frontiers in Oncology;2023-05-24

4. Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study;HPB;2022-10

5. Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study;International Journal of Surgery;2022-09